Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.42 |
| ▸ | SHBG | P04278 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MLNR | O43193 | 1/20 | 0.32 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5313949 | 1.00 | ALDH1A1 (0.45) | ALDH1A1TP53KDM4ELMNAGMNN | |
| SCHEMBL1849074 | 0.97 | ALDH1A1 (0.41) | ALDH1A1TP53KDM4ELMNAGMNN | |
| SCHEMBL7294794 | 0.91 | — | — | |
| SCHEMBL5767343 | 0.85 | ALDH1A1 (0.59) | ALDH1A1TP53KDM4ELMNAGMNN | |
| SCHEMBL1111243 | 0.85 | ALDH1A1 (0.39) | ALDH1A1TP53KDM4ELMNAGMNN | |
| SCHEMBL12803384 | 0.85 | SHBG (0.52) | ALDH1A1TP53KDM4ELMNAGMNN | |
| SCHEMBL1643439 | 0.85 | SHBG (0.52) | ALDH1A1TP53KDM4ELMNAGMNN | |
| SCHEMBL8393339 | 0.85 | ALDH1A1 (0.39) | ALDH1A1TP53KDM4ELMNAGMNN | |
| SCHEMBL19824539 | 0.85 | ALDH1A1 (0.38) | ALDH1A1TP53KDM4ELMNAGMNN | |
| SCHEMBL3221738 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119019646-A | Water-based epoxy resin and preparation method and application thereof | 江苏富琪森新材料有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-119019646-A | Water-based epoxy resin and preparation method and application thereof | 江苏富琪森新材料有限公司 | 2024-11-26 | — | — | CN | disclosed |
| US-12032287-B2 | Resist material and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-07-09 | — | — | US | disclosed |
| US-12032287-B2 | Resist material and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-07-09 | — | — | US | disclosed |
| US-20230384677-A1 | ONIUM SALT COMPOUND, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-11-30 | — | — | US | disclosed |
| US-11236443-B2 | Fibers formed from a blend of a modified aliphatic-aromatic copolyester and theremoplastic starch | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2022-02-01 | — | — | US | disclosed |
| CN-108291016-B | Polycarbonate resin, method for producing same, and film | 帝人株式会社 | 2021-08-17 | — | — | CN | disclosed |
| US-20210063873-A1 | RESIST MATERIAL AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-03-04 | — | — | US | disclosed |
| US-20210063871-A1 | RESIST MATERIAL AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-03-04 | — | — | US | disclosed |
| US-20210002792-A1 | Fibers Formed from a Blend of a Modified Aliphatic-Aromatic Copolyester and Theremoplastic Starch | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2021-01-07 | — | — | US | disclosed |
| EP-0294228-B1 | NOVEL HETEROCYCLIC PESTICIDAL COMPOUNDS | THE WELLCOME FOUNDATION LIMITED (GB) | 1992-08-26 | — | — | EP | disclosed |
| US-5130303-A | Pyridine derivative administering | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1992-07-14 | — | — | US | disclosed |
| EP-0379063-A2 | Process for preparing (trans)-4-substituted-DL-proline derivatives | E.R. SQUIBB & SONS, INC. (US) | 1990-07-25 | — | — | EP | disclosed |
| US-4937355-A | CYCLIZING PROTECTED AMINO ESTER WITH POTASSIUM AMIDE BASE, HYDROLYZING, REMOVING PROTECTIVE GROUP | E. R. SQUIBB & SONS, INC. (US) | 1990-06-26 | — | — | US | disclosed |
| EP-0294228-A2 | Novel heterocyclic pesticidal compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1988-12-07 | — | — | EP | disclosed |
| EP-0092463-B1 | PROCESS FOR THE MANUFACTURE OF MONOETHYLENE GLYCOL MONOETHERS BY HYDROGENOLYSIS OF CYCLIC ACETALS | I.C.I. FRANCE S.A. (FR) | 1985-09-25 | — | — | EP | disclosed |
| US-4045485-A | ANTIINFLAMMATORY, ANALGESIC, ANTIPYRETIC AND ANTIPRURITIC ACTIVITY | SYNTEX CORPORATION (US) | 1977-08-30 | — | — | US | disclosed |
| US-3960936-A | ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIPYRETICS, SKIN DISORDERS | SYNTEX CORPORATION (PM) | 1976-06-01 | — | — | US | disclosed |
| US-3947472-A | ANTIINFLAMMATORY, ANALGESIC, ANTIPYRETIC, ANTIPRURITIC | SYNTEX CORPORATION (PM) | 1976-03-30 | — | — | US | disclosed |
| US-3935273-A | ANTIINFLAMMATORY, ANALGESIC, ANTIPYRETIC, ANTIPRURITIC | SYNTEX CORPORATION (US) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230384677-A1 | ONIUM SALT COMPOUND, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS | INSR, INSRR, SLC6A5 | ALDH1A1 4867/4885TP53 4546/4885KDM4E 3855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.